Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ulcerative colitis
Catherine Le Berre, Sailish Honap, Laurent Peyrin‐Biroulet
The Lancet (2023) Vol. 402, Iss. 10401, pp. 571-584
Closed Access | Times Cited: 503

Showing 1-25 of 503 citing articles:

The current landscape of the antimicrobial peptide melittin and its therapeutic potential
Hai-Qian Zhang, Chengbiao Sun, Na Xu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 24
Navigating the complexities of drug development for inflammatory bowel disease
Sailish Honap, Vipul Jairath, Silvio Danese, et al.
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 7, pp. 546-562
Closed Access | Times Cited: 21
Gegen Qinlian decoction ameliorates TNBS-induced ulcerative colitis by regulating Th2/Th1 and Tregs/Th17 cells balance, inhibiting NLRP3 inflammasome activation and reshaping gut microbiota
Yingnan Hu, Jingyi Tang, Yongfeng Xie, et al.
Journal of Ethnopharmacology (2024) Vol. 328, pp. 117956-117956
Closed Access | Times Cited: 16
Ulcerative colitis: clinical biomarkers, therapeutic targets, and emerging treatments
Phurpa Wangchuk, Karma Yeshi, Alex Loukas
Trends in Pharmacological Sciences (2024)
Closed Access | Times Cited: 15
Two-Year Efficacy and Safety of Mirikizumab Following 104 Weeks of Continuous Treatment for Ulcerative Colitis: Results From the LUCENT-3 Open-Label Extension Study
Bruce E. Sands, Geert R. D’Haens, David B. Clemow, et al.
Inflammatory Bowel Diseases (2024) Vol. 30, Iss. 12, pp. 2245-2258
Open Access | Times Cited: 14
Understanding the therapeutic toolkit for inflammatory bowel disease
Sophie Vieujean, Vipul Jairath, Laurent Peyrin‐Biroulet, et al.
Nature Reviews Gastroenterology & Hepatology (2025)
Closed Access | Times Cited: 2
Oral administration of Folium Artemisiae Argyi-derived exosomes-like nanovesicles can improve ulcerative colitis by regulating intestinal microorganisms
Yishu Li, Shao Su, Yuanhao Zhou, et al.
Phytomedicine (2025) Vol. 137, pp. 156376-156376
Closed Access | Times Cited: 1
Tamuzimod in patients with moderately-to-severely active ulcerative colitis: a multicentre, double-blind, randomised, placebo-controlled, phase 2 induction trial
Bruce E Sands, Remo Panaccione, Geert R. D’Haens, et al.
˜The œLancet. Gastroenterology & hepatology (2025)
Closed Access | Times Cited: 1
Colon‐Targeted Ginseng Polysaccharides‐Based Microspheres for Improving Ulcerative Colitis via Anti‐Inflammation and Gut Microbiota Modulation
Dongxue Huo, Yanfei Li, Lijun Song, et al.
Advanced Healthcare Materials (2025)
Closed Access | Times Cited: 1
Discovery of a Novel CRBN-Recruiting cGAS PROTAC Degrader for the Treatment of Ulcerative Colitis
Peng He, Chengming Wen, Xinyu Zhang, et al.
Journal of Medicinal Chemistry (2025)
Closed Access | Times Cited: 1
Acute severe ulcerative colitis trials: the past, the present and the future
Sailish Honap, Vipul Jairath, Bruce E. Sands, et al.
Gut (2024) Vol. 73, Iss. 10, pp. 1763-1773
Closed Access | Times Cited: 13
Lactate Protects Intestinal Epithelial Barrier Function from Dextran Sulfate Sodium-Induced Damage by GPR81 Signaling
Xiaojing Li, Zhijie Yao, Jin Qian, et al.
Nutrients (2024) Vol. 16, Iss. 5, pp. 582-582
Open Access | Times Cited: 11
Metabolic Nanoregulator Remodels Gut Microenvironment for Treatment of Inflammatory Bowel Disease
Ting Xu, Xiaogang Ning, Jiayan Wu, et al.
ACS Nano (2024) Vol. 18, Iss. 9, pp. 7123-7135
Closed Access | Times Cited: 10
Red/NIR‐I‐Fluorescence Carbon Dots Based on Rhein with Active Oxygen Scavenging and Colitis Targeting for UC Therapeutics
Jiashan Xia, Jiayu Wang, Fengyuan Liu, et al.
Advanced Healthcare Materials (2024) Vol. 13, Iss. 19
Closed Access | Times Cited: 10
Dendrobium huoshanense in the treatment of ulcerative colitis: Network pharmacology and experimental validation
Liang Yao, Jing Fang, Junwei Zhao, et al.
Journal of Ethnopharmacology (2024) Vol. 323, pp. 117729-117729
Open Access | Times Cited: 9
Natural compounds target programmed cell death (PCD) signaling mechanism to treat ulcerative colitis: a review
Bo Chen, Xinqian Dong, Jinlong Zhang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 9
Polysaccharides from an edible mushroom, Hericium erinaceus, alleviate ulcerative colitis in mice by inhibiting the NLRP3 inflammasomes and reestablish intestinal homeostasis
Hao Li, Jiaxin Feng, Chang Liu, et al.
International Journal of Biological Macromolecules (2024) Vol. 267, pp. 131251-131251
Closed Access | Times Cited: 9
Biomarkers in inflammatory bowel disease: a practical guide
Jennifer Clough, Michael Colwill, Andrew Poullis, et al.
Therapeutic Advances in Gastroenterology (2024) Vol. 17
Open Access | Times Cited: 9
Isorhamnetin alleviates ferroptosis-mediated colitis by activating the NRF2/HO-1 pathway and chelating iron
Yi Ru, Ying‐Li Luo, Didi Liu, et al.
International Immunopharmacology (2024) Vol. 135, pp. 112318-112318
Closed Access | Times Cited: 9
Astragalus polysaccharides alleviate DSS-induced ulcerative colitis in mice by restoring SCFA production and regulating Th17/Treg cell homeostasis in a microbiota-dependent manner
Yu Zhang, Wenting Ji, Hailong Qin, et al.
Carbohydrate Polymers (2024) Vol. 349, pp. 122829-122829
Closed Access | Times Cited: 9
Alleviative effects of exopolysaccharides from Limosilactobacillus mucosae CCFM1273 against ulcerative colitis via modulation of gut microbiota and inhibition of Fas/Fasl and TLR4/NF-κB pathways
Huizhen Li, Haitao Li, Catherine Stanton, et al.
International Journal of Biological Macromolecules (2024) Vol. 260, pp. 129346-129346
Closed Access | Times Cited: 8
Huaier Polysaccharide Alleviates Dextran Sulphate Sodium Salt-Induced Colitis by Inhibiting Inflammation and Oxidative Stress, Maintaining the Intestinal Barrier, and Modulating Gut Microbiota
Yifei Tang, Wen‐Yin Xie, Hongyu Wu, et al.
Nutrients (2024) Vol. 16, Iss. 9, pp. 1368-1368
Open Access | Times Cited: 8
Tedizolid phosphate alleviates DSS-induced ulcerative colitis by inhibiting senescence of cell and colon tissue through activating AMPK signaling pathway
Min Zhou, Zhenlin Liu, Jiayu Liu, et al.
International Immunopharmacology (2024) Vol. 135, pp. 112286-112286
Closed Access | Times Cited: 8
Traditional Chinese medicine treats ulcerative colitis by regulating gut microbiota, signaling pathway and cytokine: Future novel method option for pharmacotherapy
Tiancheng Wang, Xinyue Liu, Weijie Zhang, et al.
Heliyon (2024) Vol. 10, Iss. 6, pp. e27530-e27530
Open Access | Times Cited: 7
Colon Targeting pH‐Responsive Coacervate Microdroplets for Treatment of Ulcerative Colitis
Yinmei Tian, Qian Hu, Zhengjun Sun, et al.
Small (2024) Vol. 20, Iss. 33
Closed Access | Times Cited: 7
Page 1 - Next Page

Scroll to top